The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial

EuroIntervention 2013;9:613-619. DOI: 10.4244/EIJV9I5A98

1. Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA; 2. Cardiology Department, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain; 3. National Heart Foundation Hospital & Research Institute, Mir

Aims: This study aimed to evaluate the safety and efficacy of using the second-generation DIOR drug-coated balloons (DCB) as an adjunct to plain

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months?